Cargando…
Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway
Calcium-activated potassium ion channel-3.1 (KCa3.1) plays a pivotal role in the potassium-calcium exchange involved in atopy. This study aimed to explore the impact of lentiviral-mediated shRNA silencing KCa3.1 on allergic response in a murine allergic rhinitis (AR) model. The BALB/c mice were divi...
Autores principales: | Lin, Hai, Zheng, Chunquan, Li, Jing, Yang, Chen, Hu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536635/ https://www.ncbi.nlm.nih.gov/pubmed/26272420 http://dx.doi.org/10.1038/srep13127 |
Ejemplares similares
-
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Allergic Rhinitis: Pathophysiology and Treatment Focusing on Mast Cells
por: Zoabi, Yara, et al.
Publicado: (2022) -
Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013) -
Leptin Regulated ILC2 Cell through the PI3K/AKT Pathway in Allergic Rhinitis
por: Zeng, Qingxiang, et al.
Publicado: (2020) -
Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)